Editorial Note: Originally published in May 2025, this report has been extensively updated to reflect the evolving landscape of U.S. foreign assistance and the long-term systemic consequences of the administration’s executive actions.
Executive Summary: A Paradigm Shift in Foreign Policy
Beginning on the first day of his second term, President Donald Trump initiated a sweeping transformation of U.S. foreign assistance, moving to dismantle the existing framework of global health and humanitarian support. Through a series of rapid-fire executive orders, the administration signaled a pivot toward an “America First” doctrine that treats foreign aid not as a strategic investment in global stability, but as a discretionary expenditure to be curtailed or eliminated.
The structural changes have been profound. By ordering a 90-day comprehensive review of all foreign aid, implementing a total freeze on ongoing payments—a “stop-work order”—and moving toward the dissolution of the United States Agency for International Development (USAID), the administration has fundamentally altered the landscape of American soft power. As USAID staff and contractors face mass layoffs and the cancellation of long-standing awards, the State Department has been tasked with absorbing the remnants of global health programs. While these moves are framed as cost-saving measures, public health experts warn of a catastrophic rollback in the fight against infectious diseases, including malaria, HIV/AIDS, and tuberculosis.
Chronology of Disruption: From Policy to Implementation
The transition from traditional foreign aid policy to the current restrictive environment occurred in three distinct phases, each deepening the impact on international health outcomes.
Phase I: The Immediate Freeze (Day One – Day 90)
Upon taking office, the administration’s initial executive order established a mandatory 90-day review period for all foreign assistance. During this time, the "stop-work order" paralyzed ongoing projects. In the field, this meant that life-saving interventions—such as the distribution of insecticide-treated bed nets or the delivery of antiretroviral therapies—were effectively halted. The bureaucratic uncertainty created a vacuum that left program implementers, local health ministries, and non-governmental organizations (NGOs) unable to pay staff or secure supply chains.
Phase II: Structural Dissolution (The USAID Reorganization)
The second phase involved the systematic dismantling of USAID. Once the bedrock of U.S. humanitarian efforts, the agency has seen its operational capacity gutted. The administration’s plan involves a significant reduction in force, shedding thousands of technical experts and career civil servants. The remaining responsibilities for global health have been transferred to the State Department—a move criticized by policy experts for potentially prioritizing diplomatic signaling over technical public health efficacy.
Phase III: The Waiver Paradox (Current Status)
While the administration issued a limited waiver to allow for "life-saving" humanitarian assistance to continue, the practical application of this waiver has been severely constrained. Implementers report that the burden of proof required to access these funds is intentionally prohibitive. Consequently, even programs deemed "essential" have struggled to secure the necessary funding, leading to a de facto termination of many critical health initiatives.
Implications for Global Health Programs: The Case of PMI
The President’s Malaria Initiative (PMI), a cornerstone of U.S. global health strategy, serves as a primary case study for the current volatility.
The Erosion of Malaria Prevention
For decades, the U.S. has been the world leader in malaria control, providing millions of bed nets, diagnostic tests, and treatments. Under the current administration, the logistics pipelines for these items have been disrupted. The shift of management to the State Department has led to a lack of continuity in technical oversight.
Risk of Resurgence
Public health experts, including those from the World Health Organization (WHO), have warned that even a short-term lapse in malaria prevention can lead to an exponential increase in cases. Because malaria is a cyclical disease, the abandonment of spraying programs and net distributions risks erasing a decade of progress. In regions where malaria incidence had been brought under control, communities are now reporting a resurgence of infections, threatening to overwhelm local health systems that are already underfunded.
Supporting Data and Economic Realities
The economic rationale cited by the administration centers on fiscal conservatism and the reduction of the federal deficit. However, the cost of the current policy shift is not merely found in the balance sheet of the federal budget.
- The Cost of Inaction: Modeling by global health economists suggests that the withdrawal of U.S. support will cost the global economy billions in lost productivity as a result of increased disease burden.
- Administrative Overhead: While the administration claims savings, the cost of terminating contracts, litigating broken agreements, and managing the transition of programs to the State Department has proven to be an expensive administrative endeavor.
- Operational Void: In the absence of U.S. funding, other geopolitical actors—most notably China—have begun to fill the void. This strategic pivot may result in a long-term loss of U.S. influence in the Global South, as nations pivot toward alternative development partners.
Official Responses and Legal Challenges
The administration’s stance remains firm, with spokespeople emphasizing that these changes are necessary to ensure that "American taxpayer dollars are not wasted on programs that do not directly benefit the national interest."
Conversely, a coalition of humanitarian organizations, former government officials, and international policy institutes has launched a series of legal challenges. These lawsuits generally argue that the administration failed to follow the administrative procedures required for such significant agency restructuring and that the "stop-work" orders violate existing international agreements.
However, the judicial branch has shown a high degree of deference to the executive in matters of foreign policy. To date, these legal remedies have been limited. Courts have largely ruled that the President maintains broad discretion in determining the scope and administration of foreign aid, leaving NGOs and beneficiaries with little recourse in the legal system.
What to Watch: The Future of Global Health
As the administration continues to reorganize the Department of Health and Human Services (HHS), several key indicators will determine the future of U.S. global health efforts:
- Staffing Levels at the State Department: Observe whether the State Department successfully integrates the technical health experts formerly housed at USAID. A failure to retain this expertise will likely result in a permanent decline in the quality of U.S.-led global health interventions.
- Congressional Pushback: While the executive holds broad power, the "power of the purse" rests with Congress. Monitor upcoming budget reconciliation processes to see if legislators move to earmark funds for specific global health initiatives, effectively overriding the administration’s executive directives.
- Multilateral Agency Contributions: The administration’s relationship with organizations like the Global Fund to Fight AIDS, Tuberculosis and Malaria remains fraught. Any further reduction in contributions to these multilateral bodies would likely signal the final end of the U.S.’s traditional role as the world’s primary donor in health security.
- Epidemiological Trends: Keep a close watch on data from the WHO and local ministries of health in sub-Saharan Africa and Southeast Asia. The true measure of these executive actions will be found in the mortality and morbidity rates of preventable diseases over the next 24 to 36 months.
Conclusion: A New Era of Uncertainty
The transformation of U.S. foreign assistance represents one of the most significant shifts in American foreign policy in the post-WWII era. By dismantling the institutions that facilitated global health security, the administration has effectively signaled the end of an era defined by collaborative international development.
The consequences of these actions extend far beyond the immediate disruption of medical supplies. They strike at the heart of the U.S.-led international order, testing the resilience of global health infrastructure and the willingness of other nations to maintain programs without American support. As the world watches these events unfold, the international community is left to grapple with a new, more isolationist reality, one where the U.S. is increasingly an observer rather than an architect of global health stability.
About the Author
